AKBA
Akebia Ther
NASDAQ: AKBA · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$1.36
-4.23% today
Updated 2026-04-29
Market cap
$364.82M
P/E ratio
—
P/S ratio
1.55x
EPS (TTM)
$-0.02
Dividend yield
—
52W range
$1 – $4
Volume
2.7M
Akebia Ther (AKBA) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
4 of 8
Last 8 quarters
Avg EPS surprise
+130.9%
Last 4 quarters
Revenue YoY growth
+23.9%
Most recent quarter
EPS YoY growth
+50.0%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-3.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-11.3%
2025-11-10
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-12 | $-0.05 | -2600.0% | $1.40 | $1.46 | +4.3% |
| 2025-11-10 | $0.00 | +105.0% | $2.04 | $1.81 | -11.3% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $0.00 | $-0.05 | -2600.0% | $57.62M | +23.9% |
| 2025-09-30 | $-0.04 | $0.00 | +105.0% | $58.77M | +57.0% |
| 2025-06-30 | $-0.02 | $0.03 | +233.5% | $62.47M | +43.1% |
| 2025-03-31 | $-0.08 | $0.02 | +130.9% | $57.34M | +75.8% |
| 2024-12-31 | $-0.08 | $-0.10 | -33.3% | $46.50M | -17.3% |
| 2024-09-30 | $-0.06 | $-0.10 | -66.7% | $37.43M | -11.0% |
| 2024-06-30 | $-0.05 | $-0.04 | +20.0% | $43.65M | -22.6% |
| 2024-03-31 | $-0.08 | $-0.09 | -12.5% | $32.61M | -18.5% |
| 2023-12-31 | $-0.04 | $0.00 | +108.0% | $56.20M | — |
| 2023-09-30 | $-0.08 | $-0.08 | +0.0% | $42.05M | — |
| 2023-06-30 | $-0.02 | $-0.06 | -200.0% | $56.38M | — |
| 2023-03-31 | $-0.15 | $-0.14 | +6.7% | $40.01M | — |
Frequently asked questions
Has Akebia Ther beaten earnings estimates?
Akebia Ther has beaten Wall Street EPS estimates in 4 of its last 8 quarterly reports, with an average EPS surprise of +130.9% over the last 1 quarters.
How does AKBA stock react to earnings?
AKBA stock has moved an average of -3.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.
What is Akebia Ther's revenue growth rate?
Akebia Ther reported year-over-year revenue growth of +23.9% in its most recent quarter, with EPS growing +50.0% year-over-year.